Related Experiment Video

Updated: May 21, 2026

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
08:01

Stimulation of Notch Signaling in Mouse Osteoclast Precursors

Published on: February 28, 2017

NOTCH1 signaling as a therapeutic target in Sézary syndrome

Leslie van der Fits1, Yongjun Qin, Jacoba J Out-Luiting

  • 1Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands.

The Journal of Investigative Dermatology
|June 22, 2012
PubMed

Insights

NOTCH1 signaling is activated in Sézary syndrome (SS) cancer cells. Inhibiting this pathway decreases cancer cell viability and induces apoptosis, suggesting it as a new therapeutic target for SS.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • NOTCH signaling is crucial for development and homeostasis.
  • Dysregulated NOTCH signaling is implicated in various human cancers.
  • Sézary syndrome (SS) is a type of cutaneous T-cell lymphoma.

Purpose of the Study:

  • To investigate the role of NOTCH1 signaling in Sézary syndrome pathogenesis.
  • To determine if NOTCH1 is activated in Sézary cells.
  • To evaluate NOTCH1 inhibition as a potential therapeutic strategy for SS.

Main Methods:

  • Analysis of NOTCH1 expression in Sézary cells from patients and cell lines using immunohistochemistry.
  • Sequencing of NOTCH1 and FBXW7 genes to identify mutations.
  • Treatment of Sézary cells with gamma secretase inhibitors to block NOTCH1 signaling.

Main Results:

  • Activated NOTCH1 and its target HES1 were consistently expressed in Sézary cells.
  • No mutations were found in the coding regions of NOTCH1 or FBXW7.
  • Inhibition of NOTCH1 signaling reduced Sézary cell viability and induced apoptosis.

Conclusions:

  • NOTCH1 signaling is functionally involved in Sézary syndrome.
  • Persistent NOTCH1 activation in SS is not due to NOTCH1 or FBXW7 mutations.
  • Targeting NOTCH1 signaling offers a novel therapeutic approach for Sézary syndrome.

More Related Videos

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...